ATHRODAX HEALTHCARE INTERNATIONAL LIMITEDActive

Company number 01501798Private limited companyIncorporated 1980

Key figures

£764,221-19.1%
Net assets 2025/26
-2.4%
Average annual change 2020/21–2025/26
0500 k1 m1.5 m2020/212021/222022/232023/242024/252025/26

Like most small UK companies, ATHRODAX HEALTHCARE INTERNATIONAL LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m1.5 m2020/212021/222022/232023/242024/252025/26
Filed accounts2020/21–2025/26
2021/222022/232023/242024/252025/26
Cash at bank and in hand257,177350,389361,840206,951247,839
Total assets1,031,7991,305,2861,155,6571,064,798899,710
Total liabilities—————
Net assets / total equity942,9791,119,3671,014,210944,784764,221
Average number of employees1210121311

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: ATHRODAX HEALTHCARE INTERNATIONAL LIMITED

Company

ATHRODAX HEALTHCARE INTERNATIONAL LIMITED is a private limited company registered with Companies House under company number 01501798. It was incorporated on 13 Jun 1980. Its status is active. The registered office is in Gloucestershire (GL17). Its nature of business (SIC 2007) is wholesale of pharmaceutical goods (46460).

Accounts

The latest accounts in the database are for 2025/26 (period ending 28 Feb 2026); the company files small company accounts (filleted). Net assets were £764,221, down 19.1% on the previous year. Cash at bank and in hand was £247,839. The company had an average of 11 employees. Figures are available for 6 financial years (2020/21–2025/26).

Control and charges

One person with significant control is registered. 3 of 3 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Nov 2026. The next confirmation statement is due by 8 Dec 2026.